WallStreetZenWallStreetZen

NASDAQ: NKTR
Nektar Therapeutics Stock Ownership - Who owns Nektar Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nektar Therapeutics insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jonathan ZalevskyChief RD Officer2026-06-305,681$70.00
$397.67kSell
Howard W. RobinPresident CEO2026-06-175,500$60.81
$334.46kSell
Howard W. RobinPresident CEO2026-06-174,500$61.65
$277.43kSell
Howard W. RobinPresident CEO2026-06-164,697$60.71
$285.15kSell
Howard W. RobinPresident CEO2026-06-165,303$59.97
$318.02kSell
Jonathan ZalevskyChief RD Officer2026-06-155,538$60.71
$336.21kSell
Howard W. RobinPresident CEO2026-05-19444$65.51
$29.09kSell
Jonathan ZalevskyChief RD Officer2026-05-19199$65.51
$13.04kSell
Howard W. RobinPresident CEO2026-02-18423$73.00
$30.88kSell
Jonathan ZalevskyChief RD Officer2026-02-18180$73.00
$13.14kSell

1 of 4

NKTR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NKTR insiders and whales buy or sell their stock.

NKTR Shareholders

What type of owners hold Nektar Therapeutics stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Deep Track Capital LP54.29%18,344,000$1.29BInsider
Fmr LLC12.74%4,303,188$303.76MInstitution
John Stuart Patton8.83%2,984,703$210.69MInsider
Bvf Inc7.58%2,559,595$180.68MInstitution
Two Seas Capital LP5.80%1,959,178$138.30MInstitution
Vanguard Capital Management LLC3.54%1,197,055$84.50MInstitution
Two Sigma Investments LP2.75%930,741$65.70MInstitution
Prosight Management LP2.18%735,000$51.88MInstitution
Blackrock Inc2.05%692,650$48.89MInstitution
Morgan Stanley1.95%659,387$46.55MInstitution

1 of 3

NKTR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NKTR52.04%47.96%Net SellingNet Selling
AMLX67.16%32.84%Net SellingNet Selling
RARE84.29%15.71%Net SellingNet Selling
VCEL91.39%8.61%Net SellingNet Selling
NRIX93.24%6.76%Net SellingNet Selling
View Top Biotech Stocks

Nektar Therapeutics Stock Ownership FAQ

Who owns Nektar Therapeutics?

Nektar Therapeutics (NASDAQ: NKTR) is owned by 79.03% institutional shareholders, 72.84% Nektar Therapeutics insiders, and 0.00% retail investors. Deep Track Capital LP is the largest individual Nektar Therapeutics shareholder, owning 18.34M shares representing 54.29% of the company. Deep Track Capital LP's Nektar Therapeutics shares are currently valued at $1.33B.

If you're new to stock investing, here's how to buy Nektar Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.